News
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
1d
Pharmaceutical Technology on MSNViz.ai, Sanofi and Regeneron to link for COPD managementViz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...
Google's Veo 3 image generator has taken the internet by storm, producing ultra-realistic AI videos from scratch. Here are ...
1d
Free Malaysia Today on MSNFirst AI-generated drugs may reach market by 2030, says Insilico CEOThe pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...
Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...
Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...
GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has ...
May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today announced the launch of ...
SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...
The first drugs conceived entirely by AI will likely go on sale by the end of the decade, an pioneer in the field has said.
4d
GlobalData on MSNPharma’s AI prospects get nudged into the future with EU’s AI actExperts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...
Last year, Lonza, a Swiss CDMO, initiated an AI-enabled route scouting program to identify new methods for synthesizing novel molecules that avoid manufacturing bottlenecks and speed drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results